John B. Schenkman

John B. Schenkman's AcademicInfluence.com Rankings

John B. Schenkman

Biology

#8970

World Rank

#12118

Historical Rank

Molecular Biology

#1178

World Rank

#1204

Historical Rank

Biochemistry

#1334

World Rank

#1455

Historical Rank

biology Degrees

Download Badge

Biology

Why Is John B. Schenkman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John B. Schenkman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cytochrome P450 (1993) (1119)
Spectral studies of drug interaction with hepatic microsomal cytochrome. (1967) (1064)
The many roles of cytochrome b5. (2003) (438)
Direct Electrochemistry of Myoglobin and Cytochrome P450cam in Alternate Layer-by-Layer Films with DNA and Other Polyions (1998) (363)
Drug interaction with hepatic microsomal cytochrome. (1966) (316)
Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver. (1972) (279)
Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. (2003) (250)
Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. (2005) (235)
[6] Preparation of microsomes with calcium (1978) (199)
Substrate interaction with cytochrome P-450. (1981) (194)
Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. (2004) (174)
Studies on the nature of the type I and type II spectral changes in liver microsomes. (1970) (161)
[109] Methods for the elevation of hepatic microsomal mixed function oxidase levels and cytochrome P-450 (1967) (158)
Direct electron injection from electrodes to cytochromeP450cam in biomembrane-like films (1997) (147)
The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat. (1970) (133)
Purification and characterization of two constitutive forms of rat liver microsomal cytochrome P-450. (1982) (128)
Toxicity screening by electrochemical detection of DNA damage by metabolites generated in situ in ultrathin DNA-enzyme films. (2003) (124)
Sex differences in drug metabolism by rat liver microsomes. (1967) (115)
Testosterone metabolism by cytochrome P-450 isozymes RLM3 and RLM5 and by microsomes. Metabolite identification. (1983) (114)
Dimethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A)--in vivo and in vitro effects of metabolism by rat liver microsomes--formation of an oxygenated complex. (1972) (112)
Spin state control of the hepatic cytochrome P450 redox potential. (1979) (111)
Preparation of microsomes with calcium. (1978) (111)
Genetics and biochemistry of primary congenital glaucoma. (2003) (107)
Cytochrome P 450K of rat kidney cortex microsomes: its involvement in fatty acid - and ( -1)-hydroxylation. (1972) (105)
The nature of the reverse type I (modified type II) spectral change in liver microsomes. (1972) (100)
Hepatic mixed function oxidase activity in rapidly prepared microsomes (1972) (98)
Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. (1990) (96)
Chemical characterization of protein-protein interactions between cytochrome P-450 and cytochrome b5. (1985) (94)
Hepatic cytochrome P-450 monooxygenase system (1982) (93)
Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism. (2001) (92)
Relationship between malondialdehyde production and arachidonate consumption during NADPH-supported microsomal lipid peroxidation. (1982) (90)
Roles of Cytochrome P450 in Development (2001) (90)
Biochemical applications of ultrathin films of enzymes, polyions and DNA. (2008) (89)
On the use of nicotinamide in assays for microsomal mixed-function oxidase activity. (1967) (87)
Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites. (2007) (85)
Studies on three microsomal electron transfer enzyme systems. Specificity of electron flow pathways. (1977) (84)
Efficient bioelectronic actuation of the natural catalytic pathway of human metabolic cytochrome P450s. (2011) (81)
Purification and characterization of a new form (RLM2) of liver microsomal cytochrome P-450 from untreated rat. (1985) (79)
Responses to insulin by two forms of rat hepatic microsomal cytochrome P-450 that undergo major (RLM6) and minor (RLM5b) elevations in diabetes. (1987) (72)
Interactions between cytochrome P450 and cytochrome b5. (1999) (71)
The cytochrome P-450-containing mono-oxygenase system of rat kidney cortex microsomes. (1973) (71)
The many roles of cytochrome b-5 in hepatic microsomes. (1976) (70)
Spectral analyses of cytochromes P450. (2006) (70)
Optimization of Electrochemical and Peroxide‐Driven Oxidation of Styrene with Ultrathin Polyion Films Containing Cytochrome P450cam and Myoglobin (2003) (69)
The cytochrome P450 2B4-NADPH cytochrome P450 reductase electron transfer complex is not formed by charge-pairing. (1992) (65)
Epoxidation of styrene by human cyt P450 1A2 by thin film electrolysis and peroxide activation compared to solution reactions. (2003) (64)
Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. (1989) (63)
Composition Changes in Hepatic Microsomal Cytochrome P-450 During Onset of Streptozocin-Induced Diabetes and During Insulin Treatment (1988) (63)
On the problem of possible other forms of cytochrome P450 in liver microsomes. (1969) (63)
Ethanol increases cytochromes P450IIE, IIB1/2, and IIIA in cultured rat hepatocytes. (1991) (63)
Differences in the mechanism of functional interaction between NADPH-cytochrome P-450 reductase and its redox partners. (1986) (63)
Purification and properties of cytochrome P-450 obtained from liver microsomes of untreated rats by lauric acid affinity chromatography. (1978) (63)
Quantitative analyses of electrostatic interactions between NADPH-cytochrome P450 reductase and cytochrome P450 enzymes. (1994) (62)
Metabolism of progesterone and estradiol by microsomes and purified cytochrome P-450 RLM3 and RLM5. (1984) (60)
Temperature-dependent spin equilibrium of microsomal and solubilized cytochrome P-450 from rat liver. (1979) (60)
A study of the interaction of a series of substituted barbituric acids with the hepatic microsomal monooxygenase. (1972) (59)
Bioelectronic delivery of electrons to cytochrome P450 enzymes. (2011) (55)
The interaction of cytochrome b5 with four cytochrome P-450 enzymes from the untreated rat. (1985) (53)
Molecular Aspects of Monooxygenases and Bioactivation of Toxic Compounds (1991) (51)
Characterization of the biochemical and structural phenotypes of four CYP1B1 mutations observed in individuals with primary congenital glaucoma (2008) (50)
Newer aspects of substrate binding to cytochrome P-450. (1973) (49)
Protein film electrochemistry of microsomes genetically enriched in human cytochrome p450 monooxygenases. (2005) (49)
PRODUCTION OF MEMBRANE WHORLS IN RAT LIVER BY SOME INHIBITORS OF PROTEIN SYNTHESIS (1974) (49)
Purification to homogeneity and enzymological characterization of a functional covalent complex composed of cytochromes P-450 isozyme 2 and b5 from rabbit liver. (1987) (48)
EPR measurements of substrate interaction with cytochrome P-450. (1966) (48)
Spectral analyses of cytochromes P450. (1998) (48)
The effect of microsomal fatty acids and other lipids on the spin state of partially purified cytochrome P-450. (1980) (47)
Synergistic metabolic toxicity screening using microsome/DNA electrochemiluminescent arrays and nanoreactors. (2008) (45)
Evidence of binary complex formations between cytochrome P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase of hepatic microsomes. (1986) (45)
Steroid metabolism by constitutive cytochromes P450 (1992) (44)
Studies on Three Microsomal Electron Transfer Enzyme Systems: Effects of Alteration of Component Enzyme Levels in Vivo and in Vitro (1975) (43)
Expression of cytochrome P4501b1 (Cyp1b1) during early murine development. (2004) (43)
Calorimetric study of microsomal membrane. (1977) (43)
Cyp1b1 Protein in the Mouse Eye during Development: An Immunohistochemical Study (2007) (41)
Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process. (1994) (40)
Reduction kinetics of purified rat liver cytochrome P-450. Evidence for a sequential reaction mechanism dependent on the hemoprotein spin state. (1984) (40)
Phosphorylation of cytochrome P450: regulation by cytochrome b5. (1989) (39)
Kinetic studies of benzpyrene and hydroxybenzpyrene metabolism. (1976) (39)
Electrochemiluminescent/voltammetric toxicity screening sensor using enzyme-generated DNA damage. (2007) (39)
Alteration of Microsomal Biotransformation in the Liver in Cholestasis 1 (1970) (38)
Kinetics of hepatic cytochrome P-450 reduction: correlation with spin state of the ferric heme. (1982) (36)
Kinetics of cytochrome P-450 reduction: evidence for faster reduction of the high-spin ferric state. (1985) (36)
The effects of temperature and substrates on component reactions of the hepatic microsomal mixed-function oxidase. (1972) (35)
Biochemical properties of rat liver mitochondrial aldehyde dehydrogenase with respect to oxidation of formaldehyde. (1976) (35)
Mechanism of interaction between cytochromes P-450 RLM5 and b5: evidence for an electrostatic mechanism involving cytochrome b5 heme propionate groups. (1986) (35)
Further characterization of RLM2 and comparison with a related form of cytochrome P-450, RLM2b. (1988) (34)
The Role of Cytochrome P-450 in Microsomal Mixed Function Oxidation Reactions (1968) (34)
Relationship between phosphorylation and cytochrome P450 destruction. (1990) (33)
Monoclonal antibodies to rat liver cytochrome P-450 2c/RLM5 that regiospecifically inhibit steroid metabolism. (1989) (33)
Genotoxicity screening for N-nitroso compounds. Electrochemical and electrochemiluminescent detection of human enzyme-generated DNA damage from N-nitrosopyrrolidine. (2007) (32)
Inverse relationship between cytochrome P-450 phosphorylation and complexation with cytochrome b5. (1987) (32)
Physiological Significance and Expression of P450s in the Developing Eye (2006) (31)
Mechanism of cholestasis: III. Interaction of synthetic detergents with the microsomal cytochrome P-450 dependent biotransformation system in vitro A comparison between the effects of detergents, the effects of bile acids, and the findings in bile duct ligated rats (1971) (31)
Evidence against participation of cytochrome b5 in the hepatic microsomal mixed-function oxidase reaction. (1973) (31)
Influence of cytochrome b5 on the stoichiometry of the different oxidative reactions catalyzed by liver microsomal cytochrome P-450. (1987) (30)
Mechanism of cholestasis. 2. Effect of bile acids on the microsomal electron transfer system in vitro. (1970) (30)
The rate-limiting step in aminopyrine demethylase of rat liver microsomes. (1970) (30)
Hepatic organelle interaction. I. Spectral investigation during drug biotransformation. (1972) (30)
Immunochemical studies on the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c (P-450) reductase in drug oxidation. (1971) (29)
Metabolic toxicity screening using electrochemiluminescence arrays coupled with enzyme-DNA biocolloid reactors and liquid chromatography-mass spectrometry. (2012) (29)
α-Glycerophosphate Dehydrogenase Activity in Rat Spermatozoa (1965) (28)
Evaluating enzymes that generate genotoxic benzo[a]pyrene metabolites using sensor arrays. (2005) (28)
Applications of polyion films containing biomolecules to sensing toxicity. (2000) (28)
Enhanced expression of CYP1B1 in Escherichia coli. (2000) (28)
Charge-dependent sidedness of cytochrome P450 forms studied by quartz crystal microbalance and atomic force microscopy. (2001) (28)
CYP1B1, a developmental gene with a potential role in glaucoma therapy (2009) (28)
Xenobiotic‐metabolizing Cytochromes P450 in Ontogeny: Evolving Perspective (2004) (27)
Influences of substrates of different microsomal electron transfer pathways on the oxidation-reduction kinetics of microsomal cytochrome b5. (1978) (27)
Evaluation of electrochemiluminescent metabolic toxicity screening arrays using a multiple compound set. (2011) (27)
Rapid LC-MS drug metabolite profiling using microsomal enzyme bioreactors in a parallel processing format. (2009) (26)
Elucidating organ-specific metabolic toxicity chemistry from electrochemiluminescent enzyme/DNA arrays and bioreactor bead-LC-MS/MS (2015) (26)
Induction of diabetes and evaluation of diabetic state on P450 expression. (1991) (25)
Alteration of hepatic microsomal enzymes by griseofulvin treatment of mice. (1977) (25)
Control of electrochemical and ferryloxy formation kinetics of cyt P450s in polyion films by heme iron spin state and secondary structure. (2009) (25)
Decrease in the levels of a constitutive cytochrome P-450 (RLM5) in hepatic microsomes of diabetic rats. (1987) (25)
Regioselective hydroxylation of prostaglandins by constitutive forms of cytochrome P-450 from rat liver: formation of a novel metabolite by a female-specific P-450. (1988) (24)
Active oxygen in liver microsomes: mechanism of epinephrine oxidation. (1979) (24)
Isolation and comparison of four cytochrome P-450 enzymes from phenobarbital-induced rat liver: three forms possessing identical NH2-terminal sequences. (1985) (24)
Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors. (2009) (23)
Enzyme-DNA biocolloids for DNA adduct and reactive metabolite detection by chromatography-mass spectrometry. (2008) (22)
Hepatic organelle interaction. 3. Mitochondrial modification of microsomal drug metabolism. (1973) (22)
Cytochrome P-450 reduction exhibits burst kinetics. (1980) (22)
Toxicity screening using biosensors that measure DNA damage. (2007) (22)
Electrochemical genotoxicity screening for arylamines bioactivated by N-acetyltransferase. (2008) (21)
Inhibition of cytochrome-P450 reductase by polyols has an electrostatic nature. (1992) (21)
Inhibition of nadph-driven microsomal lipid peroxidation by cytosol factor(s). Effect of a fat-free, high carbohydrate diet. (1976) (21)
The contribution of the microsomal electron transport pathway to the oxidative metabolism of liver. (1970) (21)
The relationship between the pH-induced spectral change in ferriprotoheme and the substrate-induced spectral change of the hepatic microsomal mixed-function oxidase. (1968) (20)
Dissection of cytochrome P-450 isozymes (RLM) from fractions of untreated rat liver microsomal proteins. (1982) (20)
Effect of phenobarbital and 3,4-benzpyrene treatment of rats on the microsomal binding and hydroxylation of nortriptyline and desmethyl-imipramine: evidence for qualitative changes in cytochrome P-450-ligand interaction following phenobarbital pretreatment. (1972) (20)
Reductive metabolism of halothane by purified cytochrome P-450. (1988) (20)
4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series. (1977) (19)
AN ANTITHYROTOXIC ASSAY BASED UPON THE RESPONSE OF RAT LIVER ALPHA-GLYCEROPHOSPHATE DEHYDROGENASE. (1964) (19)
Thin multicomponent films for functional enzyme devices and bioreactor particles. (2014) (19)
Influence of thiolate ligation on the heme electronic structure in microsomal cytochrome P-450 and model compounds: resonance Raman spectroscopic evidence (1989) (18)
Differences in the spectral interactions between NADPH-cytochrome P-450 reductase and a series of cytochrome P-450 enzymes. (1986) (18)
High-throughput metabolic toxicity screening using magnetic biocolloid reactors and LC-MS/MS. (2010) (18)
Immunocytochemical staining of the RLM6 form of cytochrome P-450 in oligodendrocytes and myelin of rat brain. (1991) (17)
SPECTRAL INVESTIGATIONS ON CYTOCHROME-P-450 (1969) (17)
Hepatic organelle interaction. IV. Mechanism of succinate enhancement of formaldehyde accumulation from endoplasmic reticulum N-dealkylations (1976) (15)
Substrate influence on interaction between cytochrome P450 and cytochrome b5 in microsomes. (1996) (15)
The role of the mitochondria in rat liver mixed function oxidation reactions. (1972) (15)
Hepatic microsomal mixed function oxidase. (1970) (15)
Hepatic organelle interaction. II. Effect of tricarboxylic acid cycle intermediates on N-demethylation and hydroxylation reactions in rat liver. (1972) (15)
Accurate DNA fragment sizing by capillary electrophoresis with laser-induced fluorescence array for detection of sequence specificity of DNA damage. (2008) (15)
Metabolic action of urethan on protein synthesis and drug oxidation in normal and regenerating liver. (1972) (14)
On the significance of drug-induced spectral changes in liver microsomes. (1972) (14)
Molecular and Applied Aspects of Oxidative Drug Metabolizing Enzymes (1999) (14)
Screening reactive metabolites bioactivated by multiple enzyme pathways using a multiplexed microfluidic system. (2013) (14)
Characterizing metabolic inhibition using electrochemical enzyme/DNA biosensors. (2009) (13)
Direct Electrochemistry of Cytochrome P450 Reductases in Surfactant and Polyion Films (2007) (13)
Genotoxicity-related chemistry of human metabolites of benzo[ghi]perylene (B[ghi]P) investigated using electro-optical arrays and DNA/microsome biocolloid reactors with LC-MS/MS. (2013) (12)
Reaction of drugs with microsomal liver hydroxylase: Its influence on drug action (2004) (12)
The effects of albumin upon the spectral changes and metabolism by the hepatic microsomal fraction. (1977) (12)
Isolation and purification of constitutive forms of microsomal cytochrome P450. (1998) (12)
Microsomal biotransformation system in cholestasis. (1972) (11)
KINETIC AND SPECTRAL EVIDENCE FOR MULTIPLE SPECIES OF CYTOCHROME P-450 IN LIVER MICROSOMES (1977) (11)
Examination of extinction coefficients of soluble and membrane-bound cytochromes P-450 and P-420. (1973) (10)
Human cyt P450 mediated metabolic toxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) evaluated using electrochemiluminescent arrays. (2009) (10)
THE MITOCHONDRIAL ROLE IN HEPATIC CELL MIXED‐FUNCTION OXIDATIONS * (1973) (10)
Cytochrome P-450 alterations in the BB/Wor spontaneously diabetic rat. (1988) (9)
Cytochrome P450-Dependent Monooxygenase: An Overview (1991) (9)
Molecular cloning of a cDNA for rat diabetes-inducible cytochrome P450RLM6: hormonal regulation and similarity to the cytochrome P4502E1 gene. (1992) (9)
Oxidation of esterified arachidonate by rat liver microsomes. (1986) (9)
Status of the cytochrome P-450 cycle (1981) (9)
Age and sex differences in constitutive forms of cytochrome P-450 of rat liver microsomes. (1986) (8)
Rate-limiting steps in drug metabolism. (1971) (8)
Screening for Reactive Metabolites Using Genotoxicity Arrays and Enzyme/DNA Biocolloids (2010) (8)
The NH2-terminal region of rabbit CYP2E1 is not essential for interaction with NADPH-cytochrome P450 reductase. (1994) (8)
Historical Background and Description of the Cytochrome P450 Monooxygenase System (1993) (7)
Chemical selectivity of nucleobase adduction relative to in vivo mutation sites on exon 7 fragment of p53 tumor suppressor gene (2015) (7)
Stimulatory and inhibitory effects of manganous and ferrous ions on epinephrine oxidation. (1979) (7)
Cholate solubilization of liver microsomal membrane components which promote NADPH-supported lipid peroxidation. (1992) (7)
Measurement of Cytochrome P‐450 (1999) (6)
Expression of cytochrome P 450 1 b 1 ( Cyp 1 b 1 ) during early murine development (2004) (6)
Molecular Aspects of Oxidative Drug Metabolizing Enzymes (1995) (6)
Interaction between microsomal electron transfer pathways. (1975) (6)
Molecular Aspects of Oxidative Drug Metabolizing Enzymes: Their Significance in Environmental Toxicology, Chemical Carcinogenesis and Health (2011) (6)
ALPHA-GLYCEROPHOSPHATE DEHYDROGENASE ACTIVITY IN RAT SPERMATOZOA. (1965) (6)
The isolation and comparison of multiple forms of CYP2B from untreated and phenobarbital-treated rabbit liver microsomes. (1995) (5)
Electrochemical biosensor featuring a two-enzyme pathway and DNA for screening toxic reactive metabolites of arylamines. (2008) (5)
The significance of drug-induced spectral changes in liver microsomal fraction. (1971) (5)
The Fate of Xenobiotics in the Body (1999) (5)
Purified cytochrome P-450: spin-state control of the haemoprotein redox potential [proceedings]. (1980) (5)
Screening for reactive metabolites using electro-optical arrays featuring human liver cytosol and microsomal enzyme sources and DNA. (2009) (4)
Stoichiometry of aminopyrine demethylation with and without NADH synergism. (1981) (4)
Introduction to Cytochrome P450 (1995) (3)
Corrections - The Nature of the Reverse Type I (Modified Type II) Spectral Change in Liver Microsomes (1973) (3)
Methyl-Cytosine-Driven Structural Changes Enhance Adduction Kinetics of an Exon 7 fragment of the p53 Gene (2017) (3)
The effect of microsomal lipids on the spin state of purified de-lipidated cytochrome P-450 [proceedings]. (1979) (3)
INFLUENCE OF SUBSTRATES OF HEPATIC MIXED FUNCTION OXIDASES ON SPIN EQUILIBRIUM OF CYTOCHROME P-450 (1980) (3)
Selective stimulation by urethan of hepatic microsomal aniline hydroxylation. (1974) (2)
Fingerprinting rat liver microsomal cytochromes P-450 as a means of delineating sexually distinctive forms (2004) (2)
Roles of CYP1B1, Optineurin, and WDR36 Gene Mutations in Glaucoma (2008) (2)
Temperature-dependent spin equilibrium of liver microsomal and solubilized cytochrome P-450 (1978) (2)
Mechanism of cholestasis. 3. Interaction of synthetic detergents with the microsomal cytochrome P-450 dependentbiotransformation system in vitro. A comparison between the effects of detergents, the effects of bile acids, and the findings in bile duct ligated rats. (1971) (2)
Protein-Protein Interactions in the P450 Monooxygenase System (1999) (2)
Protein-protein interactions (1993) (2)
Aryl Hydrocarbon Hydroxylase: Induction (1977) (2)
Functional Aspects of Protein-Protein Interactions of Cytochrome P450 Cytochrome b5 and Cytochrome P450 Reductase (1991) (2)
Possible mechanism of coupled NADPH oxidase and P-450 monooxygenase action. (1981) (2)
THE ROLES OF MEMBRANE AND SUBSTRATES IN THE MODULATION OF CYTOCHROME P-450 FUNCTION (1980) (1)
THE INFLUENCE OF FATTY ACIDS AND MEMBRANE LIPIDS ON THE SPIN STATE OF PURIFIED CYTOCHROME P450 (1980) (1)
Commentary: David Kupfer, Ph.D., 1925–2004 (2005) (1)
Active oxygen in hepatic microsomes (1976) (1)
Effect of substrates on hepatic microsomal cytochrome P-450. (1968) (1)
David Kupfer at Meetings and Play (2006) (1)
Interaction Between Cytochrome P450 and Reductase (1995) (1)
2528 – ACTIVE OXYGEN IN EPINEPHRINE OXIDATION TO ADRENOCHROME (1978) (0)
Biochemical Applications of Ultrathin Films of Enzymes, Polyions and DNA (2008) (0)
Cytochrome P-450 epitope typing in animals and humans with monoclonal antibodies to ethanol induced rat liver microsomal cytochrome P-450 (P-450et) (1986) (0)
Influence of Mn2+-Ions on Adrenaline Oxidation and Lipid Peroxidation Catalysed by Rat Liver Microsomes or by Isolated Nadph-Cytochrome C Reductase (1978) (0)
Biochemical and structural properties of four CYP1B1 mutations present in primary congenital glaucoma (PCG) patients (2008) (0)
High‐Throughput Enzyme Biocolloid Systems for Drug Metabolism and Genotoxicity Profiling Using LC–MS/MS (2013) (0)
Modulation of hepatic cytochrome p 450 oxidation reduction equilibria by substrates and lipids (1979) (0)
4-Methyl-5-amino-1 -formylisoquinolineThiosemicarbazone, a Second-GenerationAntineoplasticAgent of the a-(N) HeterocyclicCarboxaldehydeThiosemicarbazoneSeries1 (1977) (0)
Comparative analysis of orthologous CYP1B1 endobiotic metabolism (2004) (0)
Temperature induced spin state changes of liver microsomal cytochrome P-450 from control, phenobarbital (PB)- and 3-methylcholanthrene (MC)-treated rats (1979) (0)
Evaluating Enzymes that Generate Genotoxic Metabolites using Sensor Arrays Based on DNA Damage (2006) (0)
Investigating DNA Damage Inhibition of Cytochrome P450 Metabolites in DNA Sensors by Antioxidants (2006) (0)
912 – KINETICS OF BENZOPYRENE AND 3-HYDROXYBENZOPYRENE METABOLISM IN RAT LIVER MICROSOMES (1977) (0)
Protein Film Voltammetry and Biocatalytic Kinetics of Human Cytochromes P450 (2008) (0)
SPIN STATES AND REDOX POTENTIALS OF HEPATIC CYTOCHROME P450 (1980) (0)
The Mouse CYP1 Genes Appear at Different Temporal Points in Development Indicating That Cyp1a1 and Cyp1a2 Can Not Compensate for the Deficiency of the Congenital Glaucoma Gene Cyp1b1 (2003) (0)
Genotoxicity Sensors and Arrays Applied to Nitrosamines (2007) (0)
Testosterone Metabolism by Cytochrome RLMB and by Microsomes (1983) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John B. Schenkman?

John B. Schenkman is affiliated with the following schools:

John B. Schenkman's Academic­Influence.com Rankings

Why Is John B. Schenkman Influential?

John B. Schenkman's Published Works

Published Works

What Schools Are Affiliated With John B. Schenkman?

John B. Schenkman's AcademicInfluence.com Rankings